Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

174
Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
174

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical Oncologist and NHS Commissioner Perspectives on Reirradiation for Recurrent Cancer.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026
Same author

Patient Perspectives on Reirradiation for Recurrent Cancer, to Inform Future Clinical Trial Design.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026
Same author

Response to 'Dose Accumulation for Pelvic Stereotactic Ablative Radiotherapy Reirradiation. In Regard to Slevin et al.'

Clinical oncology (Royal College of Radiologists (Great Britain))·2025
Same author

Improving hybrid image and structure-based deformable image registration for large internal deformations.

Physics in medicine and biology·2024
Same author

Comparison of Meal Patterns Across Common Racial Groups in the UK and the USA, Examining Associations with Weight Status and Diet Quality: a Secondary Analysis of NDNS and NHANES Datasets.

Journal of racial and ethnic health disparities·2023
Same author

Re-irradiation: From Cell Lines to Patients, Filling the (Science) Gap in the Market.

Clinical oncology (Royal College of Radiologists (Great Britain))·2023

Related Experiment Video

Updated: Sep 20, 2025

Stereotactic Radiosurgery for Gynecologic Cancer
10:35

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

18.3K

Dose Accumulation for Pelvic Stereotactic Ablative Radiotherapy Reirradiation.

F Slevin1, C O'Hara2, J Entwisle2

  • 1Leeds Institute of Medical Research, University of Leeds, Leeds, LS9 7TF, UK; Department of Clinical Oncology, Leeds Teaching Hospitals NHS Trust, Beckett Street, Leeds, LS9 7TF, UK.

Clinical Oncology (Royal College of Radiologists (Great Britain))
|May 28, 2025
PubMed
Summary
This summary is machine-generated.

This study evaluated cumulative radiation doses in patients receiving pelvic stereotactic ablative radiotherapy (SABR) reirradiation. No severe toxicity was observed, suggesting feasibility of advanced dose evaluation methods.

Keywords:
Dose accumulationimage registrationpelvic cancerreirradiationstereotactic ablative radiotherapystereotactic body radiotherapy

More Related Videos

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
08:54

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

14.4K
Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

2.9K

Related Experiment Videos

Last Updated: Sep 20, 2025

Stereotactic Radiosurgery for Gynecologic Cancer
10:35

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

18.3K
Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
08:54

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

14.4K
Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

2.9K

Area of Science:

  • Radiation Oncology
  • Medical Physics
  • Oncology

Background:

  • Normal tissue dose constraints for reirradiation are not well-established.
  • Accurate cumulative dose evaluation is challenging due to anatomical changes and fraction size.

Purpose of the Study:

  • To retrospectively evaluate cumulative normal tissue doses in pelvic stereotactic ablative radiotherapy (SABR) reirradiation.
  • To assess the feasibility of advanced dose evaluation methods and gather preliminary data on safe cumulative doses.

Main Methods:

  • Retrospective analysis of 56 patients undergoing pelvic SABR reirradiation.
  • Deformable image registration (DIR) to transfer original dose distributions to reirradiation CT scans.
  • Calculation of cumulative doses in equivalent dose in 2-Gy fractions (EQD2) and summed maximum doses (D0.5 cc).

Main Results:

  • Cumulative doses up to 82.8 Gy (rectum), 110.2 Gy (bladder), 69.8 Gy (colon), 101.4 Gy (sacral plexus), and 108.1 Gy (vessels) were observed.
  • Small bowel received cumulative doses up to 111.9 Gy (D0.5 cc).
  • No severe toxicity events were attributed to reirradiation or cumulative doses.

Conclusions:

  • Demonstrated feasibility of 3D evaluation of cumulative normal tissue doses in pelvic SABR reirradiation.
  • Preliminary data suggest no observed toxicity related to delivered cumulative or reirradiation doses.